This, however, is in sharp contrast to Bandic et al. [11] who described a 40% NY-ESO-1 positive rate in their study of recurrent ductal breast cancer, and a high 74% MAGE-A4 positivity was also described in the same study. Here, MAGEA4 is linked to breast carcinoma.